Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oligometastatic Directed Radiotherapy for Patients With Castration Resistant Prostate Cancer

NCT07038304 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT07038304
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07038304 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oligometastatic Directed Radiotherapy for Patients With Castration Resistant Prostate Cancer
Lead sponsor
University Medical Center Groningen
Phase
Phase 2
Overall status
Recruiting
Start date
January 3, 2025
Completion date
January 3, 2029
Enrollment
35 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

castration resistant metastatic prostate cancer, oligoprogressive metastatic disease, prostate cancer (adenocarcinoma), radiotherapy